A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer.
EUROPEAN UROLOGY ONCOLOGY(2024)
关键词
Fumarate hydratase deficient,Immunotherapy,Poly ADP-ribose polymerase inhibitor,Renal cell carcinoma,Renal medullary cancer,Metastatic,Programmed death-ligand 1,Succinate dehydrogenase deficient,SMARCB1,Von Hippel-Lindau altered
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要